EXONDYS 51 ETEPLIRSEN INJECTION
Live / Registered — Registered (as of 19 May 2020)
What this means for you
Registered since 19 May 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87175636
- Registration number
- 6059005
- Mark type
- Design + words
- Filed
- 19 Sept 2016
- Published for opposition
- 21 Feb 2017
- Registered
- 19 May 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
Owner
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 19 May 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jul 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Apr 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Mar 2020 — USE AMENDMENT FILED
- 31 Mar 2020 — TEAS STATEMENT OF USE RECEIVED
- 27 Sept 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2019 — SOU EXTENSION 5 GRANTED
- 23 Sept 2019 — SOU EXTENSION 5 FILED
- 26 Sept 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Sept 2019 — SOU TEAS EXTENSION RECEIVED
- 20 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Apr 2019 — SOU EXTENSION 4 GRANTED